Eficácia e segurança de pembrolizumabe mais lenvatinibe em participantes com tumores sólidos selecionados previamente tratados
The purpose of this study is to determine the safety and efficacy of combination therapy with pembrolizumab (MK-3475) and lenvatinib (E7080/MK-7902) in participants with triple negative breast cancer (TNBC), ovarian cancer,